Nu Skin Cuts Q3 Revenue Outlook As Delta Variant Disrupts Sales

Nu Skin Enterprises Inc NUS expects third-quarter revenue of $637 million -$642 million (consensus $710.11 million), down from the previous guidance of $700 million - $730 million.
Nu Skin noted unanticipated government restrictions had impacted its ability to sell and distribute products, with the largest impact in Mainland China and Southeast Asia.
"Our third-quarter revenue was softer than anticipated as the delta variant created unexpected disruptions in many of our markets," said CEO Ryan Napierski.
The company will release full third-quarter results and provide updated guidance after the market closes on November 3, 2021.
Nu Skin anticipates annual 2021 revenue to be up modestly year over year.
Price Action: NUS shares are trading lower by 4.05% at $49.8 in premarket on the last check Monday.

Momentum18.90

Growth2.58

Quality2.23

Value88.28

Short

Medium

Long